Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.

Chen G, Yang T, Gu Q, Ni XH, Zhao ZH, Ye J, Meng XM, Liu ZH, He JG, Xiong CM.

Respirology. 2014 May;19(4):608-15. doi: 10.1111/resp.12283. Epub 2014 Apr 1.

PMID:
24689969
[PubMed - in process]
2.

Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.

Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR.

Heart. 2011 Jul;97(13):1054-60. doi: 10.1136/hrt.2011.224857. Epub 2011 May 10.

PMID:
21558476
[PubMed - indexed for MEDLINE]
3.

Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.

Zhao QH, Peng FH, Wei H, He J, Chen FD, Di RM, Jiang X, Jiang R, Chen YJ, Heresi GA, Jing ZC.

Am J Cardiol. 2012 Aug 1;110(3):433-9. doi: 10.1016/j.amjcard.2012.03.042. Epub 2012 May 4.

PMID:
22560769
[PubMed - indexed for MEDLINE]
4.

N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.

Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T.

Am J Cardiol. 2006 Aug 15;98(4):525-9. Epub 2006 Jun 28.

PMID:
16893710
[PubMed - indexed for MEDLINE]
5.

[Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].

Mazovets OL, Trifonov IR, Katrukha AG, Bereznikova AV, Medvedeva MV, Deev AD, Gratsianksiĭ NA.

Kardiologiia. 2008;48(1):24-9. Russian.

PMID:
18260992
[PubMed - indexed for MEDLINE]
6.

Soluble ST2 and N-terminal pro-brain natriuretic peptide combination. Useful biomarker for predicting outcome of childhoodpulmonary arterial hypertension.

Chida A, Sato H, Shintani M, Nakayama T, Kawamura Y, Furutani Y, Inai K, Saji T, Matsuoka R, Nonoyama S, Nakanishi T.

Circ J. 2014;78(2):436-42. Epub 2013 Dec 4.

PMID:
24304538
[PubMed - in process]
Free Article
7.

Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.

Chi SY, Kim EY, Ban HJ, Oh IJ, Kwon YS, Kim KS, Kim YI, Kim YC, Lim SC.

Lung. 2012 Jun;190(3):271-6. doi: 10.1007/s00408-011-9363-7. Epub 2012 Jan 14.

PMID:
22246552
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.

Mathai SC, Bueso M, Hummers LK, Boyce D, Lechtzin N, Le Pavec J, Campo A, Champion HC, Housten T, Forfia PR, Zaiman AL, Wigley FM, Girgis RE, Hassoun PM.

Eur Respir J. 2010 Jan;35(1):95-104. doi: 10.1183/09031936.00074309. Epub 2009 Jul 30.

PMID:
19643943
[PubMed - indexed for MEDLINE]
Free Article
9.

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.

Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Arthritis Res Ther. 2012 Jun 12;14(3):R143. doi: 10.1186/ar3876.

PMID:
22691291
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.

Nickel N, Golpon H, Greer M, Knudsen L, Olsson K, Westerkamp V, Welte T, Hoeper MM.

Eur Respir J. 2012 Mar;39(3):589-96. doi: 10.1183/09031936.00092311. Epub 2011 Sep 1.

PMID:
21885392
[PubMed - indexed for MEDLINE]
Free Article
11.

Plasma soluble ST2 levels correlate with disease severity and predict clinical worsening in patients with pulmonary arterial hypertension.

Zheng YG, Yang T, He JG, Chen G, Liu ZH, Xiong CM, Gu Q, Ni XH, Zhao ZH.

Clin Cardiol. 2014 Jun;37(6):365-70.

PMID:
25068163
[PubMed - in process]
12.

Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.

Harutyunyan M, Gøtze JP, Winkel P, Johansen JS, Hansen JF, Jensen GB, Hilden J, Kjøller E, Kolmos HJ, Gluud C, Kastrup J.

Immunobiology. 2013 Jul;218(7):945-51. doi: 10.1016/j.imbio.2012.10.015. Epub 2012 Nov 7.

PMID:
23294528
[PubMed - indexed for MEDLINE]
13.

Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension.

Malhotra R, Paskin-Flerlage S, Zamanian RT, Zimmerman P, Schmidt JW, Deng DY, Southwood M, Spencer R, Lai CS, Parker W, Channick RN, Morrell NW, Elliott CG, Yu PB.

Pulm Circ. 2013 Apr;3(2):369-80. doi: 10.4103/2045-8932.110445.

PMID:
24015338
[PubMed]
Free PMC Article
14.

[Relationship between serum uric acid levels and patient conditions and prognosis in idiopathic pulmonary arterial hypertension].

Li ZN, He JG, Liu ZH, Gu Q, Ni XH, Cheng XS, Xiong CM.

Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3261-4. Chinese.

PMID:
23328510
[PubMed - indexed for MEDLINE]
15.

[Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].

Mazovets OL, Trifonov IR, Katrukha AG, Gratsianskiĭ NA.

Kardiologiia. 2009;49(1):34-8. Russian.

PMID:
19166399
[PubMed - indexed for MEDLINE]
16.

Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension.

Nickel N, Kempf T, Tapken H, Tongers J, Laenger F, Lehmann U, Golpon H, Olsson K, Wilkins MR, Gibbs JS, Hoeper MM, Wollert KC.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):534-41. doi: 10.1164/rccm.200802-235OC. Epub 2008 Jun 19.

PMID:
18565955
[PubMed - indexed for MEDLINE]
17.

Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.

Tigen K, Karaahmet T, Cevik C, Gurel E, Mutlu B, Basaran Y.

Am J Med Sci. 2009 Feb;337(2):109-15. doi: 10.1097/MAJ.0b013e31818128b5.

PMID:
19214026
[PubMed - indexed for MEDLINE]
18.

Pulmonary Arterial Hypertension: Screening, Management, and Treatment [Internet].

McCrory DC, Coeytaux RR, Schmit KM, Kraft B, Kosinski AS, Mingo AM, Vann LM, Gilstrap DL, Hargett CW, Lugogo NL, Heidenfelder BL, Posey R, Irvine RJ, Wing L, Pendergast K, Dolor RJ.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr.

PMID:
23741759
[PubMed]
Books & Documents
19.

Treatment goals of pulmonary hypertension.

McLaughlin VV, Gaine SP, Howard LS, Leuchte HH, Mathier MA, Mehta S, Palazzini M, Park MH, Tapson VF, Sitbon O.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D73-81. doi: 10.1016/j.jacc.2013.10.034. Review.

PMID:
24355644
[PubMed - indexed for MEDLINE]
20.

Ghrelin and its relation with N-terminal brain natriuretic peptide, endothelin-1 and nitric oxide in patients with idiopathic pulmonary hypertension.

Yang D, Liu Z, Yang Z.

Cardiology. 2013;124(4):241-5. doi: 10.1159/000348368. Epub 2013 Apr 6.

PMID:
23571554
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk